Umoja Biopharma
umoja-biopharma.comLocations
Seattle, WA, USA · University of Washington, Seattle, WA, USA
industry
Pharmaceuticals
Size
51 - 200 employees
Stage
Other
founded in
2019
Umoja Biopharma focuses on innovative immunotherapy by reprogramming T cells within the patient's body to target cancer effectively. The company offers scalable therapeutic regimens designed for solid tumors and hematological cancers that typically respond poorly to current treatments. Its in-house CAR T-cell gene therapy platform aims to improve patient outcomes across various stages of cancer.
Something looks off?Open jobs at Umoja Biopharma
On-site & Remote
Job function
Seniority
Salary